2013-02-08 14:43:16 -
SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to produce reports on a company's attractiveness to long-term investors.
Ilhavo, Portugal — SADIF Investment Analytics, announces a new summary due diligence report covering the following companies:
Report Summary for: PT Radiant Utama Interinsco Tbk is a below average quality company with a neutral outlook. PT Radiant Utama Interinsco Tbk has weak business growth and is run by mediocre management. The trend in PT Radiant Utama Interinsco Tbk fair value exchange rate against its closest rated-competitor, PT Perdana Karya Perkasa Tbk, has been appreciating over the past 2 weeks. When compared to its closest competitor, PT Radiant Utama Interinsco Tbk shows similar overvaluation and is equally likely to underperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from
SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-RUIS
Report Summary for: Surya Citra Media Tbk PT is an above average quality company with a neutral outlook. Surya Citra Media Tbk PT has strong business growth and is run by efficient management. The trend in Surya Citra Media Tbk PT fair value exchange rate against its closest rated-competitor, PT Media Nusantara Citra Tbk, has been depreciating over the past 2 weeks. When compared to its closest competitor, Surya Citra Media Tbk PT shows greater undervaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-SCMA
Report Summary for: PT Millennium Pharmacon Int. Tbk is an average quality company with a neutral outlook. PT Millennium Pharmacon Int. Tbk has weak business growth and is run by passable management. The trend in PT Millennium Pharmacon Int. Tbk fair value exchange rate against its closest rated-competitor, PT Mustika Ratu Tbk, has been depreciating over the past 2 weeks. When compared to its closest competitor, PT Millennium Pharmacon Int. Tbk shows similar overvaluation and is equally likely to outperform the market.
The report has been distributed to Thomson Reuters and other major research aggregators and can be also purchased directly from SADIF-Investment Analytics at:
www.sadifanalytics.com/stockmarks/company-49-SDPC
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering twenty four different markets and over 18,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.